Lv22
146 积分 2023-12-03 加入
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
3小时前
待确认
Laccase‐Copper Nanohybrids as Highly Active Catalysts for Bio‐degradation
29天前
已完结
Fine-Tuning the Active-Site Microenvironment of β-Galactosidase to Enhance the Synthesis Ability of Galactooligosaccharides while Minimizing the Impairment to Transglycosylation Activity
29天前
已完结
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects
1个月前
已完结
Topical delivery of human single-domain antibody targeting IL-33 for inhibiting mucosal inflammation
1个月前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
2个月前
已完结
Decoding nattokinase efficacy: From digestion and absorption to lipid pathway modulation in high-fat diet-induced atherosclerosis
5个月前
已完结
皖公网安备34019202002308
